Home - Products - Others - Other Targets - Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)

Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)

CAS No. 93965-89-0

Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)( ——— )

Catalog No. M41195 CAS No. 93965-89-0

[Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ac-[Tyr1,D-Phe2]-GRF (1-29) amide (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
  • Description
    [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human), a growth hormone releasing factor (GRF) analogue, is a vasoactive intestinal peptide (VIP) antagonist.
  • In Vitro
    Cell Proliferation Assay Cell Line:C6 rat glioblastoma cells Concentration:0.1 pM-10 nM Incubation Time:3 days Result:Induced a dose-dependent cell proliferation increase.
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VIP
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    93965-89-0
  • Formula Weight
    3476.09
  • Molecular Formula
    C157H252N44O43S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Waelbroeck M, et al. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist. Endocrinology. 1985 Jun;116(6):2643-9.?
molnova catalog
related products
  • NRX-1933

    NRX-1933 is a molecular glue and enhances the interaction between an oncogenic transcription factor, β-Catenin, and its cognate E3 ligase, SCFβ-TrCP.

  • Hexaminolevulinate h...

    Hexaminolevulinate hydrochloride has approved for cystoscopic detection of papillary bladder cancer and it also is a fluorescent agent.

  • PLH2058

    PLH2058 is a compound that can be used to regulate, limit or inhibit AVIL (advillin) expression. It can be used in the treatment of cancer.